Vimarsana
Biggest News Aggregation in the World

Page 4 - Herbert Boyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Herbert Boyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Herbert Boyer Today - Breaking & Trending Today

The promise of patient-centered biotechnology - Vimarsana News

The promise of patient-centered biotechnology

Every revolution rises up against an order in need of reform. For the orphan drug revolution, that order was the pharmaceutical industry of the 1970s.

not only "playing god", but patenting god and inventing evil viruses...... - Vimarsana News

not only "playing god", but patenting god and inventing evil viruses......

GUS DOES NOT BELIEVE IN GOD. BUT GUS THINKS THAT ANYTHING THAT IS ALIVE SHOULD NOT BE PATENTED. ESPECIALLY BY "AMERICA". THE "NEW" mRNA VACCINE IS A BIT OF AN ARTIFICIAL BASTARD THAT DOES NOT WORK EFFICIENTLY. MEANWHILE THE MEDIA WAS PUSHED TO EXTOLD THE VIRTUES OF THIS VACCINE AND NOTHING ELSE.

Biotechnology is being forced onto us without anyone knowing the consequences - Vimarsana News

Biotechnology is being forced onto us without anyone knowing the consequences

There are 37 trillion cells that make up the human body. Each of these cells contains the original genetic information from the very first cell. Our DNA is a thousand times smaller than the cell, [...]

Transgenic mustard can be an economic boon - Vimarsana News

Transgenic mustard can be an economic boon

GENETIC engineering took off in the early 1970s when biochemists Herbert Boyer and Stanley Cohen inserted DNA from one bacterium into another. Organisms thus developed are called genetically modified (GM) or transgenic, where genes have been transferred from one organism to an unrelated organism, e.

The Ecosystem: European Patent Office survey shows strict novelty requirement is undermining high-potential inventions in Europe - Vimarsana News

The Ecosystem: European Patent Office survey shows strict novelty requirement is undermining high-potential inventions in Europe

The European Patent Office (EPO) has been looking again at the need for a grace period in the European Patent Convention. Last month it published the results of a survey that found only a small minority of its users would take advantage of such a mechanism, but also that the lack of a grace period is stopping universities from commercialising some of their research. As a result, Europe may be missing out on lucrative new products, start-ups, and even potential unicorns.